English   español  

Browsing by Author Mateos, Maria Victoria

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 135  next >
RightsPreviewIssue DateTitleAuthor(s)Type
closedAccessaccesoRestringido.pdf.jpg2013A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease controlPaiva, Bruno; Vidriales, Maria Belén; Martínez-López, Joaquín; Mateos, Maria Victoria; Ocio, Enrique M. CSIC ORCID ; Gutiérrez, Norma Carmen; Díaz-Mediavilla, J.; Orfao, Alberto CSIC ORCID ; Lahuerta, Juan José; Bladé, Joan; San Miguel, Jesús F. CSIC ORCIDartículo
openAccessnovelnano.pdf.jpg2018A novel nano-immunoassay method for quantification of proteins from CD138-purified myeloma cells: Biological and clinical utilityMisiewicz-Krzeminska, Irena; Corchete, Luis A.; Rojas, Elizabeta A. CSIC ORCID; Martínez-López, Joaquín; García-Sanz, Ramón; Oriol, Albert; Bladé, Joan; Lahuerta, Juan José; San Miguel, Jesús F. CSIC ORCID; Mateos, Maria Victoria; Gutiérrez, Norma Carmenartículo
openAccessA Phase II Study of Venetoclax_Gasparetto_PV_Art2021.pdf.jpgNov-2021A Phase II Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple MyelomaGasparetto, Cristina; Bowles, Kristian M.; Abdallah, Al-Ola; Morris, Lura; Mander, Gudrun; Coppola, Sheryl; Wang, J.; Ross, J. A.; Bueno, Orlando F.; Arriola, Emma; Mateos, Maria Victoriaartículo
closedAccessaccesoRestringido.pdf.jpg2017A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myelomaLaubach, Jacob P.; Moslehi, Javid J.; Francis, Sanjeev A.; San Miguel, Jesús F. CSIC ORCID; Sonneveld, Pieter; Orlowski, R. Z.; Moreau, Philippe; Rosiñol, Laura; Faber Jr., Edward A.; Voorhees, Peter; Mateos, Maria Victoria; Marquez, Loreta; Feng, Huaibao; Desai, Avinash; Velde, Helgi van de; Elliott, Jennifer; Shi, Hongliang; Dow, Edward; Jobanputra, Nishith; Esseltine, Dixie-Lee; Niculescu, Liviu; Anderson, Kenneth; Lonial, Sagar; Richardson, Paul G.artículo
openAccessA simple score to predict_Encinas_PV_Art2022.pdf.jpg2022A simple score to predict early severe infections in patients with newly diagnosed multiple myelomaEncinas, Cristina; Hernández-Rivas, José Ángel; Oriol, Albert; Rosiñol, Laura; Blanchard, María Jesús; Bellón, José María; García-Sanz, Ramón; Rubia, Javier de la; López de la Guía, Ana; Jiménez-Ubieto, Ana; Jarque, Isidro; Iñigo, Belén; Dourdil, Mª Victoria; Arriba, Felipe de; Cuéllar Pérez-Ávila, Clara; Gonzalez, Yolanda; Hernandez, Miguel T.; Bargay, Joan; Granell, Miquel; Rodríguez-Otero, Paula; Silvent, Maialen; Cabrera, Carmen; Ríos, Rafael; Alegre, Adrian; Gironella, Mercedes; Gonzalez, Marta-Sonia; Sureda, Anna; Sampol, Antonia; Ocio, Enrique M. CSIC ORCID ; Krsnik, Isabel; García, Antonio; García-Mateo, Aránzazu; Soler, Joan Alfons; Martín, Jesús; Arguiñano, José M.; Mateos, Maria Victoria; Bladé, Joan; San-Miguel, Jesús; Lahuerta, Juan José; Martínez-López, Joaquínartículo
closedAccessaccesoRestringido.pdf.jpg2017Absence of spontaneous response improvement beyond day +100 after autologous stem cell transplantation in multiple myelomaFernández de Larrea, Carlos; Dávila, Julio; Isola, I.; Ocio, Enrique M. CSIC ORCID ; Rosiñol, Laura; García-Sanz, Ramón; Cibeira, M.T.; Tovar, N.; Rovira, M.; Mateos, Maria Victoria; Miguel, J. S.; Bladé, Joanartículo
openAccess4 randomized trials.pdf.jpg2013Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trialsBringhen, Sara; Mateos, Maria Victoria; Lahuerta, Juan José; San Miguel, Jesús F. CSIC ORCID; Palumbo, Antonioartículo
closedAccessaccesoRestringido.pdf.jpg2017Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myelomaRojas, Elizabeta A. CSIC ORCID; Corchete, Luis A.; San-Segundo, Laura; Martínez-Blanch, Juan F.; Codoñer, Francisco M.; Paíno, Teresa CSIC ORCID; Puig, Noemi; García-Sanz, Ramón; Mateos, Maria Victoria; Ocio, Enrique M. CSIC ORCID ; Misiewicz-Krzeminska, Irena; Gutiérrez, Norma Carmenartículo
openAccessflowcytometry.pdf.jpg2013Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometryPessoa de Magalhães, Roberto J.; Vidriales, Maria Belén; Paiva, Bruno; Fernández, Carlos; García-Sanz, Ramón; Mateos, Maria Victoria; Gutiérrez, Norma Carmen; Lécrevisse, Quentin; Blanco, Juan F.; Martínez-López, Joaquín; Sobral da Costa, E.; Ocio, Enrique M. CSIC ORCID ; Pérez-Andrés, Martin CSIC ORCID; Lahuerta, Juan José; San Miguel, Jesús F. CSIC ORCID; Orfao, Alberto CSIC ORCID artículo
openAccessAnti-BCMA_Puertas_PV_Art2022.pdf.jpg2022Anti-BCMA cAR T-cell therapy: changing the natural history of multiple myelomaPuertas Martínez, Borja; Mateos, Maria Victoria; González-Calle, Verónicaeditorial
openAccessAssociation_Garderet_PV_Art2018.pdf.jpg2018Association between response kinetics and outcomes in relapsed/refractory multiple myeloma: analysis from TOURMALINE-MM1Garderet, Laurent; Laubach, Jacob P.; Stoppa, Anne-Marie; Hari, Parameswaran; Cavo, Michele; Ludwig, Heinz; Mateos, Maria Victoria; Luptakova, Katarina; Lin, Jianchang; Yung, Godwin; Velde, Helgi van de; Berg, Deborah; Moreau, Philippe; Richardson, Paul G.artículo
openAccessB-Cell Regeneration_Mendoça_PV_Art2021.pdf.jpg3-Apr-2021B-cell regeneration profile and minimal residual disease status in bone marrow of treated multiple myeloma patientsMendonça de Pontes, Robéria; Flores-Montero, Juan; Sanoja-Flores, Luzalba CSIC ORCID; Puig, Noemi; Pessoa de Magalhães, Roberto J.; Corral-Mateos, A.; Salgado, Anna Beatriz; García-Sánchez, O.; Pérez-Morán, José; Mateos, Maria Victoria; Burgos, Leire; Paiva, Bruno; Marvelde, Jeroen G. te; Velden, Vincent H. J. van der; Aguilar, Carlos; Bárez, Abelardo; García-Mateo, Aránzazu; Labrador, Jorge; Leoz, P.; Aguilera-Sanz, C.; Orfao, Alberto CSIC ORCID artículo
closedAccessaccesoRestringido.pdf.jpg2010BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML)Santamaría, Carlos; Chillón, M. del Carmen; García-Sanz, Ramón; Caballero, Maria Dolores; Mateos, Maria Victoria; Sarasquete, María Eugenia; Díaz-Mediavilla, J.; San Miguel, Jesús F. CSIC ORCID; González, Marcos CSIC ORCID artículo
closedAccessaccesoRestringido.pdf.jpg2020Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myelomaMaia, Catarina; Puig, Noemi; Cedena, Maria-Teresa; Vázquez, Iria; Chillón, M. del Carmen; Calasanz, Mª Jose; García-Sanz, Ramón; González, Marcos CSIC ORCID ; Gutiérrez, Norma Carmen; Martínez-López, Joaquín; Pérez, José J.; Merino, Juana; Moreno, Cristina CSIC; Burgos, Leire; Alignani, Diego; Prosper, Felipe; Matarraz, Sergio; Orfao, Alberto CSIC ORCID ; Oriol, Albert; Teruel, Ana-Isabel; Paz, Raquel de; Arriba, Felipe de; Hernandez, Miguel T.; Palomera, Luis; Martínez, Rafael; Rosiñol, Laura; Mateos, Maria Victoria; Lahuerta, Juan José; Bladé, Joan; San Miguel, Jesús F. CSIC ORCID; Paiva, Brunoartículo
closedAccessaccesoRestringido.pdf.jpg2014Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapyMateos, Maria Victoria; Bringhen, Sara; Richardson, Paul G.; Lahuerta, Juan José; García-Sanz, Ramón; San Miguel, Jesús F. CSIC ORCID; Palumbo, Antonioartículo
closedAccessaccesoRestringido.pdf.jpg2007Bortezomib in multiple myelomaMateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2011Bortezomib in the upfront treatment of multiple MyelomaSan Miguel, Jesús F. CSIC ORCID; Mateos, Maria Victoriacapítulo de libro
openAccessBortezomib Plus Melphalan.pdf.jpg2010Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA TrialMateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCIDartículo
openAccessBortezomib plus.pdf.jpg2008Bortezomib plus melphalan and prednisone for initial treatment of multiple myelomaSan Miguel, Jesús F. CSIC ORCID; Mateos, Maria Victoriaartículo
closedAccessaccesoRestringido.pdf.jpg2014Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched studyMorabito, Fortunato; Bringhen, Sara; Mateos, Maria Victoria; Lahuerta, Juan José; San Miguel, Jesús F. CSIC ORCID; Palumbo, Antonioartículo